GlaxoSmithKline Pakistan Ltd historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2026-10-19 | 312.50 | 316.00 | 310.05 | 313.98 | 313.98 | 113,894 |
| 2026-10-16 | 311.00 | 315.99 | 310.03 | 312.45 | 312.45 | 13,698 |
| 2026-10-15 | 312.48 | 313.80 | 310.00 | 311.85 | 311.85 | 82,470 |
| 2026-10-14 | 311.10 | 313.50 | 309.00 | 312.44 | 312.44 | 57,509 |
| 2026-10-13 | 310.00 | 312.99 | 310.00 | 311.19 | 311.19 | 62,009 |
| 2026-10-12 | 312.00 | 314.88 | 310.00 | 312.00 | 312.00 | 63,979 |
| 2026-10-09 | 313.80 | 317.98 | 312.01 | 316.60 | 316.60 | 138,904 |
| 2026-10-08 | 314.59 | 315.50 | 312.59 | 312.85 | 312.85 | 54,661 |
| 2026-10-07 | 314.50 | 315.50 | 313.80 | 314.59 | 314.59 | 56,438 |
| 2026-10-06 | 307.85 | 315.50 | 305.00 | 314.49 | 314.49 | 118,662 |
| 2026-10-05 | 312.20 | 312.20 | 306.20 | 307.82 | 307.82 | 62,717 |
| 2026-10-02 | 314.50 | 314.50 | 311.00 | 312.18 | 312.18 | 40,346 |
| 2026-10-01 | 313.75 | 314.99 | 312.00 | 313.55 | 313.55 | 132,608 |
| 2026-09-30 | 316.00 | 317.23 | 312.00 | 312.94 | 312.94 | 103,555 |
| 2026-09-29 | 317.99 | 317.99 | 314.01 | 314.58 | 314.58 | 39,731 |
| 2026-09-28 | 315.00 | 317.49 | 314.00 | 316.42 | 316.42 | 65,260 |
| 2026-09-25 | 315.59 | 317.00 | 312.00 | 314.37 | 314.37 | 87,742 |
| 2026-09-24 | 323.00 | 323.00 | 314.00 | 315.59 | 315.59 | 118,541 |
| 2026-09-23 | 323.00 | 326.05 | 320.55 | 321.36 | 321.36 | 122,302 |
| 2026-09-22 | 321.00 | 324.00 | 319.10 | 322.57 | 322.57 | 71,084 |
| 2026-09-21 | 321.00 | 323.00 | 317.55 | 322.61 | 322.61 | 100,137 |
Page 1 of 1 · 21 trading days
Stock splits
No stock splits on record.
Dividends
| Ex-date | Amount |
|---|---|
| 2026-09-02 | 7.0000 PKR |
| 2026-04-22 | 12.0000 PKR |
| 2025-09-05 | 5.0000 PKR |
| 2025-04-18 | 10.0000 PKR |
| 2022-04-15 | 7.0000 PKR |
| 2021-04-19 | 6.5000 PKR |
| 2020-05-13 | 6.0000 PKR |
| 2019-04-16 | 7.0000 PKR |
Open, high, low and close are as traded (PKR). Adjusted close accounts for splits and dividends. Educational only, not financial advice.